Free Trial

Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Prosperity Wealth Management Inc.

Doximity logo with Medical background
Remove Ads

Prosperity Wealth Management Inc. cut its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 42.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,315 shares of the company's stock after selling 3,935 shares during the quarter. Prosperity Wealth Management Inc.'s holdings in Doximity were worth $284,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Global Retirement Partners LLC boosted its position in Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after acquiring an additional 440 shares during the last quarter. UMB Bank n.a. boosted its holdings in Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock valued at $31,000 after purchasing an additional 235 shares during the last quarter. Farther Finance Advisors LLC boosted its holdings in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after purchasing an additional 603 shares during the last quarter. Larson Financial Group LLC boosted its holdings in Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after purchasing an additional 250 shares during the last quarter. Finally, Morse Asset Management Inc acquired a new position in Doximity in the 3rd quarter valued at about $46,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares of the company's stock, valued at approximately $366,463.20. This represents a 75.87 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 37.40% of the company's stock.

Remove Ads

Doximity Stock Performance

Shares of NASDAQ:DOCS traded down $3.50 during trading hours on Thursday, reaching $60.81. The stock had a trading volume of 1,970,742 shares, compared to its average volume of 2,430,474. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21. The firm's 50 day moving average is $63.47 and its 200-day moving average is $52.31. The stock has a market capitalization of $11.35 billion, a price-to-earnings ratio of 60.81, a P/E/G ratio of 4.10 and a beta of 1.34.

Analyst Upgrades and Downgrades

DOCS has been the topic of several recent analyst reports. KeyCorp decreased their target price on shares of Doximity from $70.00 to $65.00 and set an "overweight" rating on the stock in a report on Wednesday, January 8th. Morgan Stanley upgraded shares of Doximity from an "underweight" rating to an "equal weight" rating and boosted their target price for the company from $33.00 to $53.00 in a report on Thursday, November 14th. Mizuho boosted their target price on shares of Doximity from $55.00 to $65.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Needham & Company LLC boosted their target price on shares of Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a report on Friday, February 7th. Finally, Leerink Partnrs upgraded shares of Doximity from a "hold" rating to a "strong-buy" rating in a report on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Doximity has an average rating of "Moderate Buy" and an average target price of $64.22.

View Our Latest Analysis on DOCS

Doximity Company Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Featured Articles

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads